Kardigan Shares Rise 1.6% in Nasdaq Debut After Upsized $400M IPO
Tom Rudovsky · Reported by Reuters
More coverage: Healthcare
Sentiment
Positive
Importance
8
Price
$17.72
Mkt Cap
0
52W Low
0
52W High
0
52W Position
Off High
Rel. Volume
Market data snapshot near publication time
Summary
Kardigan's shares rose 1.6% in their Nasdaq debut, following an upsized $400 million initial public offering. This provides the immediate market reaction to the IPO, which was previously announced as priced and successfully raised earlier today. The positive debut performance indicates strong initial investor interest in the heart drug developer.
At the time of this announcement, KARD was trading at $17.72 on NASDAQ in the Life Sciences sector. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.
Price Chart
KARD - Latest Insights
KARD
Aug 11, 2026, 7:10 AM EDT
Price at Filing:
$20.41
Real-time Price:
$14.79
Change:
-$5.62 (-28%)
Market Cap:
$1.383B
KARD
Aug 11, 2026, 7:00 AM EDT
Price at Filing:
$20.41
Real-time Price:
$14.79
Change:
-$5.62 (-28%)
Market Cap:
$1.383B
KARD
Aug 11, 2026, 7:00 AM EDT
Price at Filing:
$20.41
Real-time Price:
$14.79
Change:
-$5.62 (-28%)
Market Cap:
$1.383B
KARD
Jun 29, 2026, 4:05 PM EDT
Price at Filing:
$25.90
Real-time Price:
$14.79
Change:
-$11.11 (-43%)
Market Cap:
$1.383B
KARD
Jun 25, 2026, 4:00 PM EDT
Price at Filing:
$22.58
Real-time Price:
$14.79
Change:
-$7.79 (-34%)
Market Cap:
$1.383B